Actively Recruiting
Longitudinal Observational Study of Progression Markers in Neurodegenerative Diseases Using AI and Routine Clinical Data
Led by Casa di Cura San Raffaele Cassino · Updated on 2026-09-02
600
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a long-term observational study called MARKERS-NDD to collect data from patients with various neurodegenerative diseases. These diseases, including Parkinsons Disease, dementia, and related disorders, currently lack therapies that change their course. The study aims to improve early diagnosis and prediction of disease progression by analyzing clinical markers and using artificial intelligence to identify new diagnostic and prognostic indicators. Participants in MARKERS-NDD will be followed over 1 to 10 years during routine clinical visits. The study collects data from clinical evaluations, movement and gait analysis using motion capture and wearable sensors, brain imaging, neuropsychological and voice assessments, electroencephalography, and laboratory tests. AI-driven systems will analyze handwriting and voice patterns to detect motor and cognitive changes, supporting remote diagnosis and telemonitoring. Throughout participation, patients will undergo various assessments during normal care visits, including movement analysis, cognitive testing, brain imaging, and blood tests. Researchers will monitor and predict disease progression using these clinical markers along with AI models over up to 10 years. The study aims to develop tools to better understand neurodegenerative diseases and support their management through non-invasive, cost-effective methods.
CONDITIONS
Brief Title
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Research Team
M
Maria Francesca De Pandis, MD, PhD, Neurologist
M
Maria Gaglione
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here